Recombinant Human Serpin Peptidase Inhibitor, Clade G Member 1, HEK from MYBIOSOURCE INC.

Search, find, compare suppliers for Recombinant Human Serpin Peptidase Inhibitor, Clade G Member 1, HEK products.

Edit 
Product NameRecombinant Human Serpin Peptidase Inhibitor, Clade G Member 1, HEK
DescriptionPurity >95% as determined by SDS-PAGE. Description: SERPING1 Human Recombinant produced by transfected human cells is a single polypeptide chain containing 486 amino acids (23-500). SERPING1 is fused to an 8 amino acid His-tag at C-terminus & purified by proprietary chromatographic techniques. Introduction: Plasma protease C1 inhibitor (SERPING1) is a part of the serpin superfamily of serine protease inhibitors. SERPING1 plays an important role in regulating activation of both the complement and contact systems. That isdue to the fact that SERPING1 regulates the activation of complement factor C1 in addition to the activity of activated C1 by coupling with the active catalytic site at the light chains of C1r and C1s. SERPING1 insufficiency. MW: 55,769 Da
Size0.01 mg, 0.05 mg, 1 mg
Concentrationn/a
Applicationsn/a
Other Names[SERPING1 Human HEK; Serpin Peptidase Inhibitor, Clade G Member 1 Human Recombinant HEK; C1IN; C1INH; C1NH; HAE1; HAE2; Plasma protease C1 inhibitor; C1 esterase inhibitor; C1-inhibiting factor; Serpin G1; Name; SERPING1; SERPING1 HEK], [SERPING1; SERPING1; C1IN; C1NH; HAE1; HAE2; C1INH; C1IN; C1NH; C1 Inh; C1Inh]
Gene, Accession, CAS #[SERPING1], Gene ID: 710, NCBI: NP_000053.2, UniProt: P05155
Catalog #MBS145689
Price$140, $205, $1995
Order / More InfoRecombinant Human Serpin Peptidase Inhibitor, Clade G Member 1, HEK from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Products

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.